Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|3|327-333

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.3, 2015-05, pp. : 327-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiofrequency ablation (RFA) for palliative treatment of painful non‐small cell lung cancer (NSCLC) rib metastasis: Experience in 12 patients

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 761-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐reported depression among patients with non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 334-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 241-252

John Wiley & Sons Inc

Access to resources Recommend Favorite